Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

204 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.

NQF convened MAP in 2011, in partnership with the Centers for Medicare & Medicaid Services (CMS), to provide input to the U.S. Department of Health and Human Services (HHS) on the selection of performance measures for public reporting and performance-based payment programs. MAP is a diverse, multi-stakeholder group that includes leaders and experts from health plans, suppliers, provider organizations, community health agencies and other entities.

The Clinician Workgroup will provide recommendations on issues related to the selection and coordination of measures that would impact clinicians, particularly in the office setting, such as those in the Merit-Based Incentive Payment System (MIPS).

Dr. Butt is a licensed clinical health psychologist and Phreesia’s resident expert in patient-reported outcomes (PROs) and clinical quality measurement. At Phreesia, he works closely with health systems and provider groups to help them implement screening tools and PROs, improve health outcomes and meet quality goals.

“As a health psychologist, I am honored to have been invited to join as a subject matter expert and member of this workgroup,” said Dr. Butt. “I believe our work will help to amplify the voice of clinicians toward the selection of performance measures for federal public reporting, performance-based payment and other health programs.”

Phreesia facilitates more than 100 million visits a year. Its intake platform offers healthcare providers the ability to collect key patient-reported data, and Phreesia is also the steward of the Patient Activation Measure® (PAM®), a survey that assesses patients’ underlying knowledge, skills and confidence to manage their own health. PAM is backed by research demonstrating that higher scores are associated with better clinical outcomes, higher patient satisfaction with care and lower healthcare costs. PAM has also been successfully used as a performance metric, PAM-PM, which has been endorsed by the NQF.

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform activates patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.13
+4.31 (1.62%)
AAPL  298.87
+4.07 (1.38%)
AMD  445.50
-2.79 (-0.62%)
BAC  49.84
-0.94 (-1.85%)
GOOG  399.04
+15.22 (3.97%)
META  616.63
+13.63 (2.26%)
MSFT  405.21
-2.56 (-0.63%)
NVDA  225.83
+5.05 (2.29%)
ORCL  189.76
+2.93 (1.57%)
TSLA  445.27
+11.82 (2.73%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.